ORCHPHARMA
ORCHID PHARMA LIMITEDHealthcare
LTP
1,001.85
CHG · %
+4.3 (+0.43%)
VOL · TODAY
26.62K
PREV CLOSE
997.55
Today's range989.15 · 1,010
1,001.85
52-week range480 · 1,119.8
1,001.85
Loading candles…
Orchid Pharma Ltd., headquartered in Chennai, India, operates in the pharmaceutical and anti-infectives industries. The company is engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (FDF), with a particular focus on Cephalosporin antibiotics. It markets Enmetazobactam under the brand names EXBLIFEP and Orblicef. Orchid Pharma is noted as the only Indian pharmaceutical company with a New Chemical Entity approved in both the US and Europe. Its business activities include research on new drugs, including the development and approval of Enmetazobactam. The company serves markets in India, the US, and Europe. Orchid Pharma underwent a corporate insolvency resolution process and was acquired by the Dhanuka Group in 2020. Following this, the company has focused on high-value anti-infectives and global expansion. The company is listed under the ticker ORCHPHARMA.
ORCHPHARMA is not part of any active scan today.
This page is a live market overview for ORCHID PHARMA LIMITED (ORCHPHARMA) on the NSE. As a listed security, ORCHID PHARMA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ORCHPHARMA before placing trades on tick2trade.
As of the latest feed, ORCHPHARMA last traded at ₹1,001.85 on NSE, up ₹4.3 (0.43%) from the previous close of ₹997.55. Today's session range is ₹989.15 – ₹1,010, against a 52-week band of ₹480 – ₹1,119.8. Traded volume today stands at 26.62K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for ORCHPHARMA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ORCHPHARMA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ORCHID PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ORCHPHARMA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ORCHPHARMA option chain page linked from this overview.
// similar in healthcare314 total